Tumor lysis with LTX-401 creates anticancer immunity

ABSTRACTLocal immunotherapies such as the intratumoral injection of oncolytic compounds aim at reinstating and enhancing systemic anticancer immune responses. LTX-315 is a first-in-class, clinicall...